NCT01977352

Efficacy of Interscalene Brachial Plexus Block With Liposomal Bupivacaine for Arthroscopic Shoulder Surgery

Comparison of Cumulative Opioid Consumption After Interscalene Brachial Plexus Block With Liposomal Bupivacaine (Exparel; 88 mg in 20 cc) Versus Bupivacaine 0.25% for Arthroscopic Shoulder Surgery

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 42 (actual)
• Sponsor: St. Luke's-Roosevelt Hospital Center · Academic / Other
• Sex: All
• Age: 17 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the quality and duration of pain relief after shoulder surgery provided by a single injection of liposomal bupivacaine versus standard bupivacaine when administered as an interscalene brachial plexus block. It is hypothesized that the liposomal bupivacaine formulation will provide more effective pain relief than standard bupivacaine.

Conditions

• Shoulder Pain
• Rotator Cuff Tear

Interventions

Type	Name	Description
DRUG	Liposomal bupivacaine	liposomal bupivacaine (EXPAREL®; 88 mg in 20 cc)
DRUG	Bupivacaine 0.25%	20 cc of bupivacaine 0.25%

Timeline

• Start date: 2014-01-01
• Primary completion: 2015-02-01
• Completion: 2015-02-01
• First posted: 2013-11-06
• Last updated: 2018-04-02
• Results posted: 2018-04-02

Locations

1 site across 1 country: United States